CAS 2126928-92-3
:Clindamycin Palmitate Hydrochloride Sulfoxide (7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-α-D-galacto-octopyranose 2-palmitate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C34H63ClN2O7S·HClForma y color:White PowderPeso molecular:714.38113Clindamycin Palmitate Sulfoxide HCl
CAS:Fórmula:C34H63ClN2O7S·HClForma y color:White To Off-White SolidPeso molecular:679.40 36.46Clindamycin Palmitate Sulfoxide HCl (Mixture of Diastereomers)
CAS:Fórmula:C34H63ClN2O7S·HClPeso molecular:679.40 36.46Clindamycin Palmitate Sulfoxide Hydrochloride (>90%)
CAS:Producto controladoApplications Clindamycin Palmiitate Sulfoxide Hydrochloride, is an impurity in the synthesis of Clindamycin Palmitate Hydrochloride (C580035), a semi-synthetic antibiotic with high bioavailability. Clindamycin Palmitate is an antibacterial.
References Bharathi, Ch. et al.: J. Pharm. Biomed. Anal., 48, 1211 (2008); Platzer, D., et al.: J. Pharm. Biomed. Anal., 41, 84 (2006);Fórmula:C34H63ClN2O7S·ClHPureza:>90%Forma y color:NeatPeso molecular:715.85Clindamycin Palmitate Sulfoxide Hydrochloride
CAS:Fórmula:C34H63ClN2O7SHClPeso molecular:679.40 : 36.46Clindamycin 2-palmitate sulfoxide
CAS:Clindamycin 2-palmitate sulfoxide is a semisynthetic antibiotic, which is a derivative of clindamycin. It originates from lincomycin, a natural antibiotic produced by the bacterium *Streptomyces lincolnensis*. This compound functions as a prodrug, which is converted into its active form in the body. Its mode of action involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the ribosome, thereby preventing the growth and replication of susceptible bacteria.
Fórmula:C34H64Cl2N2O7SPureza:Min. 95%Peso molecular:715.9 g/molRef: 3D-BKD92892
Producto descatalogado
